In March 2025, the company introduced new options for a immediate-to-buyer providing of its Wegovy weight loss drug. The company set up a new pharmacy, identified as NovoCare, which might cost customers $499 every month for entry to the drug, lower than fifty percent the cost of the drug by means of other pharmaceutical distribution networks.[fifty